表紙
市場調查報告書

激化酵素抑制劑的全球市場:產業分析,市場規模,成長,趨勢,預測

Kinase Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 930860
出版日期 內容資訊 英文 251 Pages
商品交期: 最快1-2個工作天內
價格
激化酵素抑制劑的全球市場:產業分析,市場規模,成長,趨勢,預測 Kinase Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2020年02月10日內容資訊: 英文 251 Pages
簡介

本報告提供全球激化酵素抑制劑市場調查,提供市場概要,各類型·用途·流通管道·各地區的市場規模的變化與預測,成長率,銷售額·收益趨勢,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義和範圍
  • 市場區隔
  • 主要的調查目的
  • 調查亮點

第2章 前提條件與調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介和概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 波特的五力分析
  • 市場分析與預測

第5章 市場預測

  • 開發平台分析
  • 品牌分析
  • 激化酵素抑制劑研究的近幾年趨勢

第6章 全球激化酵素抑制劑市場分析與預測:各類型

  • 簡介和定義
  • 市場規模:各類型(實際成果值·預測值)
    • 非受體蛋白酪氨酸激梅(RTK)抑制劑
    • 受體蛋白酪氨酸激梅(RTK)抑制劑
    • 多激化酵素抑制劑
    • 絲胺酸/蘇胺酸激梅抑制劑
    • 蛋白激梅C抑制劑
    • Rho激化酵素抑制劑
    • 其他
  • 市場魅力分析:各類型

第7章 全球激化酵素抑制劑市場分析與預測:各用途

  • 簡介和定義
  • 市場規模:各用途(實際成果值·預測值)
    • 腫瘤
    • 發炎性疾病
    • 其他
  • 市場魅力分析:各用途

第8章 全球激化酵素抑制劑市場分析與預測:各流通管道

  • 簡介和定義
  • 市場規模:各流通管道(實際成果值·預測值)
    • 醫院藥局
    • 獨立型藥局
    • 線上藥局
  • 市場魅力分析:各流通管道

第9章 全球激化酵素抑制劑市場分析與預測:各地區

  • 主要調查結果
  • 市場規模:各地區(實際成果值·預測值)
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲地區
  • 市場魅力分析:各地區

第10章 北美

第11章 歐洲

第12章 亞太地區

第13章 南美

第14章 中東·非洲

第15章 競爭情形

  • 競爭矩陣
  • 企業的市場佔有率
  • 企業簡介
    • Boehringer Ingelheim International GmbH
    • Novartis AG
    • AstraZeneca plc
    • Pfizer, Inc.
    • F. Hoffmann-La Roche Ltd
    • Bristol-Myers Squibb Company
    • Johnson & Johnson
    • Bayer AG
    • Eisai
目錄
Product Code: TMRGL818

Scope of the Report

TMR's report on the global kinase inhibitors market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the global kinase inhibitors market for the period of 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global kinase inhibitors market from 2019 to 2027.

The report has been prepared after an extensive research. Primary research involves bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global kinase inhibitors market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global kinase inhibitors market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global kinase inhibitors market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global kinase inhibitors market.

The report delves into the competitive landscape of the global kinase inhibitors market. Key players operating in the global kinase inhibitors market have been identified and each one of them has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global kinase inhibitors market that have been profiled in this report.

Key Questions Answered:

  • What is the sales/revenue generated by the kinase inhibitors market across all regions during the forecast period?
  • What are the opportunities in the global kinase inhibitors market?
  • What are the major drivers, restraints, opportunities, and threats in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which product segment is expected to generate the highest revenue globally in 2027? Which segment is projected expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global kinase inhibitors market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global kinase inhibitors market in terms of type, application, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2027 has been provided herein. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global kinase inhibitors market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Kinase Inhibitors Market

4. Market Overview

  • 4.1. Introduction & Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. Porter's Five Forces Analysis
  • 4.4. Global Kinase Inhibitors Market Analysis and Forecast, 2017-2027

5. Market Outlook

  • 5.1. Pipeline Analysis
  • 5.2. Brand Analysis
  • 5.3. Recent Developments In Kinase Inhibitors Research

6. Global Kinase Inhibitors Market Analysis and Forecasts, by Type

  • 6.1. Introduction & Definition
  • 6.2. Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 6.2.1. Non-receptor Tyrosine Kinase Inhibitors
      • 6.2.1.1. Bruton's Tyrosine Kinase (BTK) Inhibitors
      • 6.2.1.2. BCR-ABL
      • 6.2.1.3. Janus Kinase (JAK) Inhibitor
      • 6.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)
      • 6.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors
      • 6.2.1.6. Others
    • 6.2.2. Receptor Tyrosine Kinase Inhibitors
      • 6.2.2.1. VEGFR
      • 6.2.2.2. PDGFR
      • 6.2.2.3. EGFR
      • 6.2.2.4. ALK
      • 6.2.2.5. HER2
      • 6.2.2.6. Others
    • 6.2.3. Multikinase inhibitors
    • 6.2.4. Serine/Threonine Kinase Inhibitors
    • 6.2.5. Protein Kinase C Inhibitors
    • 6.2.6. RHO Kinase Inhibitors
    • 6.2.7. Others
  • 6.3. Global Kinase Inhibitors Market Attractiveness, by Type

7. Global Kinase Inhibitors Market Analysis and Forecasts, by Application

  • 7.1. Introduction & Definition
  • 7.2. Global Kinase Inhibitors Market Value (US$) Forecast, by Application, 2017-2027
    • 7.2.1. Oncology
      • 7.2.1.1. Lung Cancer
      • 7.2.1.2. Renal cell cancer
      • 7.2.1.3. Breast Cancer
      • 7.2.1.4. Others
    • 7.2.2. Inflammatory Diseases
    • 7.2.3. Others
  • 7.3. Global Kinase Inhibitors Market Attractiveness, by Application

8. Global Kinase Inhibitors Market Analysis and Forecasts, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 8.2.1. Hospital Pharmacies
    • 8.2.2. Independent Pharmacies
    • 8.2.3. Online Pharmacies
  • 8.3. Global Kinase Inhibitors Market Attractiveness, by Distribution Channel

9. Global Kinase Inhibitors Market Analysis and Forecasts, by Region

  • 9.1. Key Findings
  • 9.2. Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Kinase Inhibitors Market Attractiveness, by Region

10. North America Kinase Inhibitors Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 10.2.1. Non-receptor Tyrosine Kinase Inhibitors
      • 10.2.1.1. Bruton's Tyrosine Kinase (BTK) Inhibitors
      • 10.2.1.2. BCR-ABL
      • 10.2.1.3. Janus Kinase (JAK) Inhibitor
      • 10.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)
      • 10.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors
      • 10.2.1.6. Others
    • 10.2.2. Receptor Tyrosine Kinase Inhibitors
      • 10.2.2.1. VEGFR
      • 10.2.2.2. PDGFR
      • 10.2.2.3. EGFR
      • 10.2.2.4. ALK
      • 10.2.2.5. HER2
      • 10.2.2.6. Others
    • 10.2.3. Multikinase inhibitors
    • 10.2.4. Serine/Threonine Kinase Inhibitors
    • 10.2.5. Protein Kinase C Inhibitors
    • 10.2.6. RHO Kinase Inhibitors
    • 10.2.7. Others
  • 10.3. North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
    • 10.3.1. Oncology
      • 10.3.1.1. Lung Cancer
      • 10.3.1.2. Renal cell cancer
      • 10.3.1.3. Breast Cancer
      • 10.3.1.4. Others
    • 10.3.2. Inflammatory Diseases
    • 10.3.3. Others
  • 10.4. North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Independent Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country, 2017-2027
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Kinase Inhibitors Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Kinase Inhibitors Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 11.2.1. Non-receptor Tyrosine Kinase Inhibitors
      • 11.2.1.1. Bruton's Tyrosine Kinase (BTK) Inhibitors
      • 11.2.1.2. BCR-ABL
      • 11.2.1.3. Janus Kinase (JAK) Inhibitor
      • 11.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)
      • 11.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors
      • 11.2.1.6. Others
    • 11.2.2. Receptor Tyrosine Kinase Inhibitors
      • 11.2.2.1. VEGFR
      • 11.2.2.2. PDGFR
      • 11.2.2.3. EGFR
      • 11.2.2.4. ALK
      • 11.2.2.5. HER2
      • 11.2.2.6. Others
    • 11.2.3. Multikinase inhibitors
    • 11.2.4. Serine/Threonine Kinase Inhibitors
    • 11.2.5. Protein Kinase C Inhibitors
    • 11.2.6. RHO Kinase Inhibitors
    • 11.2.7. Others
  • 11.3. Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
    • 11.3.1. Oncology
      • 11.3.1.1. Lung Cancer
      • 11.3.1.2. Renal cell cancer
      • 11.3.1.3. Breast Cancer
      • 11.3.1.4. Others
    • 11.3.2. Inflammatory Diseases
    • 11.3.3. Others
  • 11.4. Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Independent Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe Kinase Inhibitors Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Kinase Inhibitors Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 12.2.1. Non-receptor Tyrosine Kinase Inhibitors
      • 12.2.1.1. Bruton's Tyrosine Kinase (BTK) Inhibitors
      • 12.2.1.2. BCR-ABL
      • 12.2.1.3. Janus Kinase (JAK) Inhibitor
      • 12.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)
      • 12.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors
      • 12.2.1.6. Others
    • 12.2.2. Receptor Tyrosine Kinase Inhibitors
      • 12.2.2.1. VEGFR
      • 12.2.2.2. PDGFR
      • 12.2.2.3. EGFR
      • 12.2.2.4. ALK
      • 12.2.2.5. HER2
      • 12.2.2.6. Others
    • 12.2.3. Multikinase inhibitors
    • 12.2.4. Serine/Threonine Kinase Inhibitors
    • 12.2.5. Protein Kinase C Inhibitors
    • 12.2.6. RHO Kinase Inhibitors
    • 12.2.7. Others
  • 12.3. Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
    • 12.3.1. Oncology
      • 12.3.1.1. Lung Cancer
      • 12.3.1.2. Renal cell cancer
      • 12.3.1.3. Breast Cancer
      • 12.3.1.4. Others
    • 12.3.2. Inflammatory Diseases
    • 12.3.3. Others
  • 12.4. Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Independent Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Kinase Inhibitors Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Kinase Inhibitors Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 13.2.1. Non-receptor Tyrosine Kinase Inhibitors
      • 13.2.1.1. Bruton's Tyrosine Kinase (BTK) Inhibitors
      • 13.2.1.2. BCR-ABL
      • 13.2.1.3. Janus Kinase (JAK) Inhibitor
      • 13.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)
      • 13.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors
      • 13.2.1.6. Others
    • 13.2.2. Receptor Tyrosine Kinase Inhibitors
      • 13.2.2.1. VEGFR
      • 13.2.2.2. PDGFR
      • 13.2.2.3. EGFR
      • 13.2.2.4. ALK
      • 13.2.2.5. HER2
      • 13.2.2.6. Others
    • 13.2.3. Multikinase inhibitors
    • 13.2.4. Serine/Threonine Kinase Inhibitors
    • 13.2.5. Protein Kinase C Inhibitors
    • 13.2.6. RHO Kinase Inhibitors
    • 13.2.7. Others
  • 13.3. Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
    • 13.3.1. Oncology
      • 13.3.1.1. Lung Cancer
      • 13.3.1.2. Renal cell cancer
      • 13.3.1.3. Breast Cancer
      • 13.3.1.4. Others
    • 13.3.2. Inflammatory Diseases
    • 13.3.3. Others
  • 13.4. Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Independent Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America Kinase Inhibitors Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Kinase Inhibitors Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 14.2.1. Non-receptor Tyrosine Kinase Inhibitors
      • 14.2.1.1. Bruton's Tyrosine Kinase (BTK) Inhibitors
      • 14.2.1.2. BCR-ABL
      • 14.2.1.3. Janus Kinase (JAK) Inhibitor
      • 14.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)
      • 14.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors
      • 14.2.1.6. Others
    • 14.2.2. Receptor Tyrosine Kinase Inhibitors
      • 14.2.2.1. VEGFR
      • 14.2.2.2. PDGFR
      • 14.2.2.3. EGFR
      • 14.2.2.4. ALK
      • 14.2.2.5. HER2
      • 14.2.2.6. Others
    • 14.2.3. Multikinase inhibitors
    • 14.2.4. Serine/Threonine Kinase Inhibitors
    • 14.2.5. Protein Kinase C Inhibitors
    • 14.2.6. RHO Kinase Inhibitors
    • 14.2.7. Others
  • 14.3. Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
    • 14.3.1. Oncology
      • 14.3.1.1. Lung Cancer
      • 14.3.1.2. Renal cell cancer
      • 14.3.1.3. Breast Cancer
      • 14.3.1.4. Others
    • 14.3.2. Inflammatory Diseases
    • 14.3.3. Others
  • 14.4. Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Independent Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Israel
    • 14.5.4. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Kinase Inhibitors Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Competition Matrix
  • 15.2. Market Share Analysis, by Company (2018)
  • 15.3. Company Profiles
    • 15.3.1. Boehringer Ingelheim International GmbH
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Company Financials
      • 15.3.1.3. Growth Strategies
      • 15.3.1.4. SWOT Analysis
    • 15.3.2. Novartis AG
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Company Financials
      • 15.3.2.3. Growth Strategies
      • 15.3.2.4. SWOT Analysis
    • 15.3.3. AstraZeneca plc
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Company Financials
      • 15.3.3.3. Growth Strategies
      • 15.3.3.4. SWOT Analysis
    • 15.3.4. Pfizer, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments)
      • 15.3.4.2. Company Financials
      • 15.3.4.3. Growth Strategies
      • 15.3.4.4. SWOT Analysis
    • 15.3.5. F. Hoffmann-La Roche Ltd
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Company Financials
      • 15.3.5.3. Growth Strategies
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. Bristol-Myers Squibb Company
      • 15.3.6.1. Company Overview (HQ, Business Segments)
      • 15.3.6.2. Company Financials
      • 15.3.6.3. Growth Strategies
      • 15.3.6.4. SWOT Analysis
    • 15.3.7. Johnson & Johnson
      • 15.3.7.1. Company Overview (HQ, Business Segments)
      • 15.3.7.2. Company Financials
      • 15.3.7.3. Growth Strategies
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Bayer AG
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Company Financials
      • 15.3.8.3. Growth Strategies
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. Eisai Co., Ltd.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Company Financials
      • 15.3.9.3. Growth Strategies
      • 15.3.9.4. SWOT Analysis

List of Tables

  • Table 01: Global BCR-ABL Tyrosine Kinase Inhibitors Market Revenue (US$ Mn) Forecast, by Key Brands, 2016-2026
  • Table 02: Global EGFR Tyrosine Kinase Inhibitors Market Revenue (US$ Mn) Forecast, by Key Brands, 2016-2026
  • Table 03: Global VEGFR Tyrosine Kinase Inhibitors Market Revenue (US$ Mn) Forecast, by Key Brands, 2016-2026
  • Table 04: Global Other Tyrosine Kinase Inhibitors Market Revenue (US$ Mn) Forecast, by Key Brands, 2016-2026
  • Table 05: Patent & Market Exclusivity Overview, by Molecule (1/4)
  • Table 06: Patent & Market Exclusivity Overview, by Molecule (2/4)
  • Table 07: Patent & Market Exclusivity Overview, by Molecule (3/4)
  • Table 08: Patent & Market Exclusivity Overview, by Molecule (4/4)
  • Table 09: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 10: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 11: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 12: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 13: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017-2027
  • Table 14: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 15: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 16: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 17: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 18: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 19: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 20: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017-2027
  • Table 21: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 22: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 23: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 24: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 25: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 26: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 27: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017-2027
  • Table 28: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 29: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 30: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 31: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 32: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 33: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 34: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017-2027
  • Table 35: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 36: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 37: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 38: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 39: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 40: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 41: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017-2027
  • Table 42: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 43: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 44: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 45: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 46: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Table 47: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 48: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017-2027
  • Table 49: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 50: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

List of Figures

  • Figure 01: Global Kinase Inhibitors Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
  • Figure 02: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 03: Clinical Trial Analysis, by Phase
  • Figure 04: Clinical Trial Analysis, by Status
  • Figure 05: Global Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 06: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Figure 07: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017-2027
  • Figure 08: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Multikinase inhibitors, 2017-2027
  • Figure 09: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Serine/Threonine Kinase Inhibitors, 2017-2027
  • Figure 10: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Protein Kinase C Inhibitors, 2017-2027
  • Figure 11: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by RHO Kinase Inhibitors, 2017-2027
  • Figure 12: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2027
  • Figure 13: Global Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 14: Global Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 15: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oncology, 2017-2027
  • Figure 16: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Inflammatory Diseases, 2017-2027
  • Figure 17: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2027
  • Figure 18: Global Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 19: Global Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 20: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacies, 2017-2027
  • Figure 21: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017-2027
  • Figure 22: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017-2027
  • Figure 23: Global Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 24: Global Kinase Inhibitors Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 25: Global Kinase Inhibitors Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 26: North America Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 27: North America Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 28: North America Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 29: North America Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 30: North America Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 31: North America Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 32: North America Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 33: North America Kinase Inhibitors Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 34: North America Kinase Inhibitors Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 35: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 36: Europe Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 37: Europe Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 38: Europe Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 39: Europe Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 40: Europe Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 41: Europe Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 42: Europe Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 43: Europe Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 44: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 45: Asia Pacific Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 46: Asia Pacific Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 47: Asia Pacific Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 48: Asia Pacific Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 49: Asia Pacific Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 50: Asia Pacific Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 51: Asia Pacific Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 52: Asia Pacific Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 53: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 54: Latin America Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 55: Latin America Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 56: Latin America Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 57: Latin America Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 58: Latin America Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 59: Latin America Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 60: Latin America Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 61: Latin America Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 62: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 63: Middle East & Africa Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 64: Middle East & Africa Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 65: Middle East & Africa Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 66: Middle East & Africa Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 67: Middle East & Africa Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 68: Middle East & Africa Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 69: Middle East & Africa Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 70: Middle East & Africa Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 71: Global Kinase Inhibitors Market Share, by Company, 2018